Accéder au contenu
Merck

Competitive inhibition of cytosolic Ca2+-dependent phospholipase A2 by acteoside in RBL-2H3 cells.

Archives of pharmacal research (2012-05-31)
Ho Sun Song, Mi Young Choi, Myoung Soo Ko, Jae Min Jeong, Yong Ho Kim, Beom Hyeon Jang, Ji Hoon Sung, Min Gyu Kim, Wan Kyunn Whang, Sang Soo Sim
RÉSUMÉ

The aim of this study was to investigate whether acteoside isolated from Clerodendron trichotomum Thunberg may act as a selective inhibitor of phospholipase A(2) in RBL-2H3 cells. Acteoside dose-dependently inhibited 0.5 μM melittin-induced release of [(3)H]arachidonic acid, which was due to the inhibition of cytosolic Ca(2+)-dependent phospholipase A(2) (cPLA(2)) rather than secretory PLA(2) (sPLA(2)). In Dixon plots, the apparent K ( i ) value of acteoside on cPLA(2) was 5.9 μM and the inhibitory pattern appeared to be a competitive inhibitor. The above data, suggests that acteoside acts as a competitive inhibitor of cPLA(2) in RBL-2H3 cells.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Verbascoside, ≥99% (HPLC)
Verbascoside, primary reference standard